Dr Iris Depaz profoundly changed the model for the translation and commercialisation of medical research into the clinic in Australia, establishing a first-of-its-kind, global scientific community focused on mRNA technology and translational science. 

She led digital health projects using artificial intelligence and led the development of the first pneumococcal vaccine for ear disease in Indigenous children. She also commissioned training programs to combat vaccine hesitancy, rolled out to thousands of health professionals.

Dr Depaz was known for her visionary leadership, her mentorship of researchers moving into industry, and her ability to engage widely to create impact. She was a dedicated and passionate champion of growing pharmaceutical and health technology companies in Australia.

Dr Iris Depaz has profoundly changed the model of translation and commercialisation of medical research into the clinic in Australia, creating a first-of-its-kind, global scientific community focused on mRNA technology and translational science. She is a role model, coach and mentor to researchers moving into industry and a passionate champion of growing pharmaceutical and HealthTech companies in Australia, rather than offshoring the IP early in its development.